pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-2110 |
Genomic Coordinates | chr10: 114174105 - 114174179 |
Synonyms | hsa-mir-2110, MIR2110 |
Description | Homo sapiens miR-2110 stem-loop |
Comment | Zhu et al. incorrectly referred to this sequence as mir-1309 in . This sequence is unrelated to MIR1309 in plants. |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-2110 | ||||||||||||||||||||||||||||||||||||||||||
Sequence | 8| UUGGGGAAACGGCCGCUGAGUG |29 | ||||||||||||||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||||||||||||||
Experiments | 454 | DRVs in miRNA |
|
||||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | MRO | ||||||||||||||||||||
Synonyms | B29, C18orf3 | ||||||||||||||||||||
Description | maestro | ||||||||||||||||||||
Transcript | NM_001127174 | ||||||||||||||||||||
Other Transcripts | NM_001127175 , NM_001127176 , NM_031939 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on MRO | |||||||||||||||||||||
3'UTR of MRO (miRNA target sites are highlighted) |
>MRO|NM_001127174|3'UTR 1 GCGCAGAGCAGCAGGGAAATGGTTCTGTATGAGTGCATTGCTGAGCCATCATGTTCCCCTGTTTTATCTCACTGGATGCC 81 TCTTCTCACTGCTTGCCTCTTGGGATTGTAATGGGAAAGAGGGTGCTGGGAGAGCAATCAAAGGCAAAAATAATACATGG 161 AATTGTATGATTTTATCTAAAGTAAAATTCTAGACTGCTTTCACTTATTTCATTTCCTCCCCATACAAATTTGATGAGCA 241 GGTACACACTTTCTTTAAAACATTCCAAGTGTATATAGATTCAGTGCTTATTTCTCAGCTTTTTCTTTCTTAAGTTCATC 321 TCTGTCACCTAGCTTTTATTTTTAATACTCAATTTCTGAGGCTTAGGAGAATACTTGTTACCTTAAGCGTTTTTTTGTTT 401 TTTTGTTGTTGTTGTTTTGTTTTTTTTTAGTGTATTTGCTATTGATACTTTGCTATTGATACCTTTACTTGCCAAGATTT 481 ATTTAAAGTTGGCCAAGATACCAAGAAGGTGGCTTGCAGGGGCATCTTTGGCTTCTCATAATTTTAAACAGTCATTGCTT 561 TCAAGATCATGCTAAACAAGAATTAATAGAGAGAAAAAAATCTATAAAGCATGTGTTGAAAATCCTCAGGCTCATGATAA 641 CTTACGGGATAACAATAGTAGGTAACACCGAGTGCTTACAATTCAGTGGGCACGGTCAAAGTGCTTTTTGTAAGTTCTAT 721 TTAATACTTGCGACAACCCTGAGATAGTAAGTATTATTATTGTTCTCATTTTATAGATGAGAAAGCTAACACATAGGGAA 801 ATTAGGTAACTTTCCCCAGATAACTCAGTAAACAGTGGAGCTGGAATTCAAACATGTACGGTCTGACTTCTTGAGCCCAT 881 ACTCAATAATCATGCCATCCTGCCTTTCCATGGAATAACTGATGGATGGTTAGAAATGTTAAAAACAAAGCAAATGCAAA 961 CATCTCTGCTTCTGCTCCTCTACTAAGCCCAGTTAACTTTTGATTTTATATGTACTAAGTATACATTTTTATTAATTTAT 1041 GTGAGCTGAGTGTTTTTATTAATTACTTTTTGGCTATTAATGTCAATTATTTTGGTGATCAATCCTAGTTATCCAAGGAG 1121 TCACATCACTCGTAAAAATTACAAGAAAAATCTCTAAGTCCCTCTCACCCTCCCTCTAACCAGATTGCATCCCAAGCTTC 1201 TATAGAAACTCTGGTACCACCCCTGAATTCAGTATCCAGGCCACACCCGGAGCGTTTTGTTCAAGACAATTTAAAACACG 1281 GGGGATTATAAAAGCTATAGCTGGATCTTAAGTGGCATTCTGAGAATGAGGAACTCAATTTTCTGCTGTAGCTCCCAGGG 1361 ACAGGGTGGTGTGACACAGATGCGGGGATGAGGAGAGACCTAGGCGAGATGAGGATGTGGGAGATGGCAGACAGAGTGGC 1441 AAGTGCCAGGCAGGAATGGATTTTCTTCCTTCCTGTTCTGAATCTGAAGAACATGACAGCAAGAGATTTTAGGAGGGACA 1521 CAGGCTCACGAGCAAATGGGTGGTTCTGAGCTGTAAGCCCCCTGCCCCTCCCTAGCACCCACTCCCCGGATGCTGGCCTC 1601 TTTGAAATTTTGTTGCAAGGTTGGTTTAAACTTGATGCAGTTCCATTAAGTGATCAGTGAGTGGTCTGAGAAATGGCTGC 1681 ATGTGGCTGGCATTCAAAAAGGTGGGGATAGGGTGAGATGGGTGGGGTTACGTGCTCTGGAGTAGAAAAACCTATGCAGT 1761 TAATGTCCCTCTGTCGGTTAAAATTGTGGAAGATGCGGTTGGATTATTTGACTTTAAGATTCAATGGTAGGCTTTTATTT 1841 TGGTGGCCCCCAATGAGTCATGCCTCCTGATACTCATGTCTTTATTTAGTCCCTTCTGTTTGAATCTGGGCTGCCTTTGT 1921 GACTTGCTTTAATCAGGAGATTGTGATAAATGGCACTGTGCCGGGCATAGAAACCCTGGCAGTTTCCTCGTTTGAATTGT 2001 GGGGGAAGCCAGCTGCCACATAAGGAGTTGAACTACCAGGAACAAATGAGAGTGCCTGAGATCACCATGTGAAGGAGAAC 2081 GGAGACACCCAACCCACAGCAGAGTCTGAGGCCCGGACACATGACACAAGTTGTCCCTTCCAGCCAGACCCGAGCTGTTG 2161 AAGCTACTCCAGCTGACACCATACGGAAAAGAGACGAGCGTCTCCATCAAGCCTGTGTCAGTTGCAGAAGCATGAACAAA 2241 GAATCAAATGATTGTTGTTTTAAGTCATTAACCTTTGGGATAATTTGTCACACTGCAATAAGTAACCAGAGAAGATTCCT 2321 TATTATTAACTGTTGTCTTGGCTAATTTTGTTTTGCTCTTCATAAGTCCTCTTTGAGTTTAAATTCTATTTCCAGAAATT 2401 TATGTTATCATGAAATTTGGTGGCAAGAGCAAGGGACTATGTTTTTTTGTTTGTTTGTTTCTGTTTCTCACCATACCTAC 2481 CACAGAGCCTGGCCATGTGATTAAGGAACATTTGCTGAATGACTAAATGATTCCAAATTGTAGAGGGAATAAAGTCCAAT 2561 GTCCAGTCTGCCATTTCAGGCTTTCAACCTTCGTTTTCTTCTGTTACTCTCTTTGCTTCAGACAAGTTTGGGTCCTTTCT 2641 CTTCTCTCAACATGTCTTGTTCTCCTATACCCCCTCACCTTTGCTCAGTCTGCTATTTCTGTGTTGAGTCCCCTCCCTGC 2721 TCACCTGTACACACCCACCTGGAATCACATGCACACACACACACACACATTTCACGTGTATCTCTTATCTGTACTCCAAT 2801 GCCTAGGTCAAAGTCCTGATCCCCCCAATCAGGGGAGAGCTCAAGTCTCTGAATTCCCAGAACATTCTAGCAATATTATA 2881 CCACTTATATCTTATCTGAAAAGTTTTTTTTTGTATATGGCTTTATGTTTTTTTTTTTATCCTGTTAGATTGAAACTACA 2961 GAAGGCAGGGCTGTATCTTGTACATCATTGTATCTCCCCGGTGACTGCAAAAGTACTCTGTAAATGAATGTTGATTAGGG 3041 GGAAAAATGTCAGAAAGTCATCTGAAGCTGTCATTCCTTACTGGGAGGAGCCCATTTTGACAAATGAGGGTCACCAATTT 3121 CATTCCTTATAACCAATGTACAGGTTACTTTTATGCTTGTGCATTTCAAGTTTCCCCTTCCCCACGTTTATCTGAATGCC 3201 AACCCAAAGGTAATGTTTTGACATTTCTTAATTTTGAACATTAATTTTGAACCTTATTGAGCAGTTGAATGAAAGAAAGA 3281 AAAAAGGAATGTTCAAGTGCCCCGACCCTCATGCTAAGTGCCCAGGGTAGAGCTTTGCTTGGTCCCTGTGTCTCTGGTGC 3361 TCATGAGATAGGTCTTTCTTTCTTTATTTTTATTTTTGAGATGGAGCCTCACTCTGTCACCCAGGCTGGAGTGCAATGAC 3441 ACGATCTCGGCTCACTGCAACCTCCACCTCCTGGGTTCAAGCGATTCTCCTGTCTCAGCCTCCTGAGTAGCTGGGATTAC 3521 AGGTGCCTGCCACCATGGCTGGCTAATTTTTGTGTTTTTAGTAGAGACGGGGTTTCACCATGTTGGCCAGGCTGGTCTCA 3601 AACTCCTGACCTCAAGTGATCTGCTCACCTTGGTCTCCCAAAGTGCTGGGATTACAGGCGTGAGCCACCGCTCCTGGCTG 3681 AGATAGGTCTTTCTTAAAGGGGAGAGGGAAGTGGTGGAGAGAGAGGAGAGAAAATGACAAAGGAGGAGGCTGAGAATCTA 3761 ACAGGTGTGACCAATTCTGCTACTGAATGAGAGCAGAAGCCTGTGAACTTCCAGTTAATAGACCACTTAATTGGGGGAAC 3841 GCTTCACACGTTATAAAAAAGCACTAGAATGTTTTGAAAGCGAGAAACAACAGCTGTGTAGGGTAGCTAGCAGTTAGTGT 3921 TGTACAGAAGACAGATATTTGTGCATTTCTGCATTTTCTAAGTTTGCTGCAATGAGCATGTATTACTTTCATAGTTATAA 4001 AACACATGCAAAATGCCCTTTTAAAATGAAAAAAAAGTCCATGAGTGTAAGTGATATATATGCTTTGGAAAGCCTGGGAC 4081 GGTCATTGTTTACTCTCAATAGTATGTGTTTGCCTTTGTCTTTTTGAGACATTTTGTTTTAATCTGTTGATGACAATAAC 4161 CTGTTGATAATATAACTTGATAACAAATAAAATGACTTATGATTGATTATCATTTTAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | BC-1 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM796037. RNA binding protein: AGO2. Condition:4-Thiouridine
... - Gottwein E; Corcoran DL; Mukherjee N; et al., 2011, Cell host & microbe. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Gottwein E; Corcoran DL; Mukherjee N; et al. - Cell host & microbe, 2011
Primary effusion lymphoma (PEL) is caused by Kaposi's sarcoma-associated herpesvirus (KSHV) and frequently also harbors Epstein-Barr virus (EBV). The expression of KSHV- and EBV-encoded microRNAs (miRNAs) in PELs suggests a role for these miRNAs in latency and lymphomagenesis. Using PAR-CLIP, a technology which allows the direct and transcriptome-wide identification of miRNA targets, we delineate the target sites for all viral and cellular miRNAs expressed in PEL cell lines. The resulting data set revealed that KSHV miRNAs directly target more than 2000 cellular mRNAs, including many involved in pathways relevant to KSHV pathogenesis. Moreover, 58% of these mRNAs are also targeted by EBV miRNAs, via distinct binding sites. In addition to a known viral analog of cellular miR-155, we show that KSHV encodes a viral miRNA that mimics cellular miR-142-3p function. In summary, this study identifies an extensive list of KSHV miRNA targets, which are likely to influence viral replication and pathogenesis.
LinkOut: [PMID: 22100165]
|
CLIP-seq Support 1 for dataset GSM796037 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-1 / 4-Thiouridine |
Location of target site | ENST00000428869.2 | 3UTR | UCAAGUUUCCCCUUCCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
96 hsa-miR-2110 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT035757 | BRD4 | bromodomain containing 4 | 1 | 1 | ||||||||
MIRT035758 | NCOR2 | nuclear receptor corepressor 2 | 1 | 1 | ||||||||
MIRT035759 | FASN | fatty acid synthase | 1 | 1 | ||||||||
MIRT035760 | C10orf118 | coiled-coil domain containing 186 | 1 | 1 | ||||||||
MIRT055403 | SHOC2 | SHOC2, leucine rich repeat scaffold protein | 2 | 6 | ||||||||
MIRT066205 | MARCH9 | membrane associated ring-CH-type finger 9 | 2 | 2 | ||||||||
MIRT079365 | CCDC137 | coiled-coil domain containing 137 | 2 | 2 | ||||||||
MIRT081180 | MIDN | midnolin | 2 | 4 | ||||||||
MIRT082397 | HNRNPUL1 | heterogeneous nuclear ribonucleoprotein U like 1 | 2 | 4 | ||||||||
MIRT089000 | BCL11A | B-cell CLL/lymphoma 11A | 2 | 2 | ||||||||
MIRT133706 | SKI | SKI proto-oncogene | 2 | 4 | ||||||||
MIRT160053 | TET3 | tet methylcytosine dioxygenase 3 | 2 | 4 | ||||||||
MIRT180853 | RPRD2 | regulation of nuclear pre-mRNA domain containing 2 | 2 | 2 | ||||||||
MIRT263243 | SGPL1 | sphingosine-1-phosphate lyase 1 | 2 | 2 | ||||||||
MIRT285532 | CDT1 | chromatin licensing and DNA replication factor 1 | 2 | 2 | ||||||||
MIRT317152 | E2F3 | E2F transcription factor 3 | 2 | 4 | ||||||||
MIRT321166 | EIF4H | eukaryotic translation initiation factor 4H | 2 | 2 | ||||||||
MIRT441482 | NCEH1 | neutral cholesterol ester hydrolase 1 | 2 | 2 | ||||||||
MIRT443884 | CNKSR3 | CNKSR family member 3 | 2 | 2 | ||||||||
MIRT445877 | WBP1L | WW domain binding protein 1 like | 2 | 2 | ||||||||
MIRT446195 | GTPBP4 | GTP binding protein 4 | 2 | 2 | ||||||||
MIRT449308 | MRO | maestro | 2 | 2 | ||||||||
MIRT450301 | DRAXIN | dorsal inhibitory axon guidance protein | 2 | 2 | ||||||||
MIRT450512 | EMX1 | empty spiracles homeobox 1 | 2 | 2 | ||||||||
MIRT451534 | CIAPIN1 | cytokine induced apoptosis inhibitor 1 | 2 | 2 | ||||||||
MIRT451820 | ALDH3B1 | aldehyde dehydrogenase 3 family member B1 | 2 | 2 | ||||||||
MIRT452239 | TRAM1 | translocation associated membrane protein 1 | 2 | 2 | ||||||||
MIRT454207 | HLA-A | major histocompatibility complex, class I, A | 2 | 2 | ||||||||
MIRT455447 | EPB41L4B | erythrocyte membrane protein band 4.1 like 4B | 2 | 2 | ||||||||
MIRT456496 | PFKFB2 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 | 2 | 2 | ||||||||
MIRT457656 | SERINC1 | serine incorporator 1 | 2 | 2 | ||||||||
MIRT459819 | TPP1 | tripeptidyl peptidase 1 | 2 | 2 | ||||||||
MIRT460556 | FEM1A | fem-1 homolog A | 2 | 2 | ||||||||
MIRT462561 | STS | steroid sulfatase | 2 | 2 | ||||||||
MIRT462986 | ZNF740 | zinc finger protein 740 | 2 | 2 | ||||||||
MIRT464671 | UBE2V1 | ubiquitin conjugating enzyme E2 V1 | 2 | 2 | ||||||||
MIRT465432 | TP53 | tumor protein p53 | 2 | 2 | ||||||||
MIRT465934 | TMEM189-UBE2V1 | TMEM189-UBE2V1 readthrough | 2 | 2 | ||||||||
MIRT466015 | TMEM189 | transmembrane protein 189 | 2 | 2 | ||||||||
MIRT468122 | SH3PXD2A | SH3 and PX domains 2A | 2 | 2 | ||||||||
MIRT469652 | RAC1 | Rac family small GTPase 1 | 2 | 2 | ||||||||
MIRT469980 | PTPN14 | protein tyrosine phosphatase, non-receptor type 14 | 2 | 2 | ||||||||
MIRT473531 | MAX | MYC associated factor X | 2 | 2 | ||||||||
MIRT473596 | MARK2 | microtubule affinity regulating kinase 2 | 2 | 2 | ||||||||
MIRT473652 | MARCKSL1 | MARCKS like 1 | 2 | 2 | ||||||||
MIRT474219 | LCOR | ligand dependent nuclear receptor corepressor | 2 | 4 | ||||||||
MIRT474771 | KIAA0895L | KIAA0895 like | 2 | 2 | ||||||||
MIRT479312 | VPS72 | vacuolar protein sorting 72 homolog | 2 | 2 | ||||||||
MIRT481121 | AZIN1 | antizyme inhibitor 1 | 2 | 4 | ||||||||
MIRT481682 | AR | androgen receptor | 2 | 2 | ||||||||
MIRT482381 | AEN | apoptosis enhancing nuclease | 2 | 2 | ||||||||
MIRT483833 | UNC5B | unc-5 netrin receptor B | 2 | 4 | ||||||||
MIRT484693 | RNF11 | ring finger protein 11 | 2 | 2 | ||||||||
MIRT485238 | POGZ | pogo transposable element derived with ZNF domain | 2 | 2 | ||||||||
MIRT488748 | FXYD1 | FXYD domain containing ion transport regulator 1 | 2 | 2 | ||||||||
MIRT489147 | MRPL12 | mitochondrial ribosomal protein L12 | 2 | 4 | ||||||||
MIRT489518 | MRE11A | MRE11 homolog, double strand break repair nuclease | 2 | 8 | ||||||||
MIRT498908 | SRCAP | Snf2 related CREBBP activator protein | 2 | 2 | ||||||||
MIRT506426 | NAGK | N-acetylglucosamine kinase | 2 | 6 | ||||||||
MIRT506640 | MAPK1 | mitogen-activated protein kinase 1 | 2 | 4 | ||||||||
MIRT507332 | FAM168A | family with sequence similarity 168 member A | 2 | 2 | ||||||||
MIRT513099 | DYNAP | dynactin associated protein | 2 | 2 | ||||||||
MIRT513514 | YIPF4 | Yip1 domain family member 4 | 2 | 6 | ||||||||
MIRT521800 | POM121C | POM121 transmembrane nucleoporin C | 2 | 2 | ||||||||
MIRT525078 | FRK | fyn related Src family tyrosine kinase | 2 | 2 | ||||||||
MIRT530927 | SCIN | scinderin | 2 | 2 | ||||||||
MIRT533498 | TRIM71 | tripartite motif containing 71 | 2 | 2 | ||||||||
MIRT536787 | HNRNPD | heterogeneous nuclear ribonucleoprotein D | 2 | 2 | ||||||||
MIRT544554 | CSNK2A1 | casein kinase 2 alpha 1 | 2 | 2 | ||||||||
MIRT552977 | VAT1 | vesicle amine transport 1 | 2 | 2 | ||||||||
MIRT557358 | HAND1 | heart and neural crest derivatives expressed 1 | 2 | 2 | ||||||||
MIRT560401 | TMEM69 | transmembrane protein 69 | 2 | 2 | ||||||||
MIRT565498 | SP1 | Sp1 transcription factor | 2 | 2 | ||||||||
MIRT568962 | CACNA1C | calcium voltage-gated channel subunit alpha1 C | 2 | 2 | ||||||||
MIRT569031 | IL21R | interleukin 21 receptor | 2 | 2 | ||||||||
MIRT573224 | TRIM21 | tripartite motif containing 21 | 2 | 2 | ||||||||
MIRT574312 | ZNF703 | zinc finger protein 703 | 2 | 2 | ||||||||
MIRT620395 | MYO1H | myosin IH | 2 | 2 | ||||||||
MIRT620936 | OSMR | oncostatin M receptor | 2 | 2 | ||||||||
MIRT638166 | TMED4 | transmembrane p24 trafficking protein 4 | 2 | 2 | ||||||||
MIRT647743 | SAMD9L | sterile alpha motif domain containing 9 like | 2 | 2 | ||||||||
MIRT649991 | MSI1 | musashi RNA binding protein 1 | 2 | 2 | ||||||||
MIRT669203 | CBX8 | chromobox 8 | 2 | 2 | ||||||||
MIRT684546 | ZNF708 | zinc finger protein 708 | 2 | 2 | ||||||||
MIRT685837 | ANGEL1 | angel homolog 1 | 2 | 2 | ||||||||
MIRT688547 | DCAF16 | DDB1 and CUL4 associated factor 16 | 2 | 2 | ||||||||
MIRT693252 | HBS1L | HBS1 like translational GTPase | 2 | 2 | ||||||||
MIRT701970 | MIER3 | MIER family member 3 | 2 | 2 | ||||||||
MIRT706385 | MC2R | melanocortin 2 receptor | 2 | 2 | ||||||||
MIRT707484 | UGT2B4 | UDP glucuronosyltransferase family 2 member B4 | 2 | 2 | ||||||||
MIRT711882 | INSIG2 | insulin induced gene 2 | 2 | 2 | ||||||||
MIRT716906 | CACNB2 | calcium voltage-gated channel auxiliary subunit beta 2 | 2 | 2 | ||||||||
MIRT717638 | HLX | H2.0 like homeobox | 2 | 2 | ||||||||
MIRT719058 | ZNF281 | zinc finger protein 281 | 2 | 2 | ||||||||
MIRT723754 | NKIRAS2 | NFKB inhibitor interacting Ras like 2 | 2 | 2 | ||||||||
MIRT725479 | GPR26 | G protein-coupled receptor 26 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|